Surgical Robotics Technology
Asensus Surgical has announced that the Private Healthcare Institution Railway Clinical Hospital RZD Medicine of Rostov-on-Don, located in Rostov, Russia, has initiated its Senhance® Robotic Surgery program following the purchase of a Senhance Surgical System.
“We are excited to bring Senhance to such a prestigious, forward thinking institution. RZD Medicine is home to a high volume, multidisciplinary general surgery department that can leverage Senhance across a wide variety of procedures,” said Anthony Fernando, Asensus Surgical President and CEO. “We are excited to see hospitals in Russia starting to adopt Senhance, and we look forward to partnering with others in the region in the future.”
Asensus Surgical’s technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform). The Senhance Surgical System is powered by the Intelligent Surgical Unit™ (ISU). The ISU enables machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field and allows a surgeon to change the visualized field of view using the movement of their instruments.
“Within our high-volume general surgery department, we are focused on delivering the best outcomes to our patients by leveraging the most advanced surgical technologies available,” said Professor Aleksandr Khitharyan, M.D, A.G., Head of the Department of General Surgery at RZD Medicine. “Ultimately, our goal is to get patients back to their daily life as quickly as possible. Senhance’s broad applicability across a variety of surgical procedures, and its ability to deliver high quality, reproducible outcomes while at the same time reducing the invasiveness of procedures will allow us to accomplish our goal.”
Source: Asensus Surgical.
